|   |
| Research Topics: |
| INDEX |
| AI-chat 1 |
| PRIME 37 |
| aging 12 |
| body 2 |
| brain 17 |
| brainwave 3 |
| cancer 7 |
| climate 3 |
| cognition 10 |
| covid-19 6 |
| crime 3 |
| culture 3 |
| diabetes 6 |
| diagnostics 2 |
| disease 3 |
| drugs 1 |
| energy 1 |
| exercise 3 |
| eyes 1 |
| genetics 12 |
| gut 3 |
| heart 15 |
| immune 8 |
| kidneys 5 |
| language 2 |
| metabolism 2 |
| microbiome 2 |
| nutrition 11 |
| obesity 2 |
| physical 2 |
| politics 2 |
| pollution 2 |
| population 2 |
| practice 2 |
| privacy 2 |
| psychology 14 |
| quantum 1 |
| reproduction 2 |
| rights 1 |
| sleep 2 |
| space 1 |
| tech 2 |
| unk |
| vaccine 2 |
| virus 2 |
| war-confl |
| war-cyber 1 |
|
Scanned: 3012 Evaluated: 322 Selected: 92 |
| PRIME   BODY COGNITION   NUTRITION   PHYSICAL   | ||||||||
Aef32-1013 | Schioliosis, the Serotonin Connection | |||||||
| Quote: | Abstract Recent research has suggested a potential association between serotonin and idiopathic scoliosis, a complex spinal deformity of unknown origin. Studies have explored genetic associations, altered serotonin levels, and the effects of serotonin-related medications in the context of idiopathic scoliosis. Genetic studies have identified significant associations between idiopathic scoliosis and serotonin-related genes, indicating a potential genetic predisposition to the condition. Furthermore, altered serotonin levels have been observed in patients with idiopathic scoliosis, with lower serum serotonin levels reported compared to healthy controls. This chapter reviews some of the published genomic variants associated with idiopathic scoliosis. The effects of serotonin-related medications have also been investigated, highlighting potential therapeutic benefits. However, the exact mechanisms underlying the association between serotonin and idiopathic scoliosis remain unclear, warranting further research. While theoretical and animal models have shown connections between serotonin metabolism and idiopathic scoliosis, there are uncertainties when translating this information into clinical practice for primary care and other musculoskeletal specialty providers. This chapter outlines the serotonergic pathways of musculoskeletal function, serotonin clinical laboratory testing methods, as well as clinical management strategies including pharmacological, nutrient, dietary, and lifestyle-based options. Keywords genomicsposturescoliosisserotoninspine Author Information Show 1. Introduction Serotonin, also known as 5-hydroxytryptamine (5-HT), is a neurotransmitter that plays a crucial role in the central nervous system (CNS). It is derived from the amino acid tryptophan and is involved in numerous physiological functions, including mood regulation, sleep, appetite, and cognition. Structurally, serotonin is a monoamine neurotransmitter with a chemical formula of C10H12N2O. It contains an indole ring and an amine group, making it a member of the indoleamine class of neurotransmitters. Serotonin exerts its effects by binding to specific receptors, mainly the 5-HT receptors, which are widely distributed throughout the brain and other tissues. While serotonins involvement in mental health disorders like depression and anxiety is well-established, recent research has also highlighted its potential role in the pathogenesis of idiopathic scoliosis, a complex spinal deformity of unknown origin. | |||||||
| Article: | https://www.intechopen.com/chapters/1157328 | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
| PRIME   BODY GENETICS   METABOLISM   NUTRITION   OBESITY   | ||||||||
Aef32-1025 | FNIP1 variants are associated with favourable metabolism in 1 million humans | |||||||
| Quote: | FNIP1 knockdown in primary human hepatocytes induces lipid breakdown and lysosomal gene expression, while combined hepatic knockdown of Fnip1 with its paralogue Fnip2 or knockdown of its interactor Flcn protect against weight gain, reduce liver fat and enhance insulin sensitivity in mice fed a high-fat diet. Our study implicates the FNIP1 pathway in human energy metabolism and highlights its inhibition as a potential therapeutic strategy in cardiometabolic disease. | |||||||
| Article: | https://pubmed.ncbi.nlm.nih.gov/42557317/ | |||||||
| Search Similar: | Brave Mojeek Startpage Dogpile Bing Googl Lycos Utub Yaho | |||||||
|
Javilk's Research Links Newsletter for Week 32 Updated 08/15/2026-01:24:35 AM What interests you? What have you found? Tell me! Drop me a note to subscribe or submit something. |